Results 141 to 150 of about 44,475 (226)

Effects of imeglimin on experimental diabetic neuropathy in streptozotocin‐induced diabetic rats

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 6, Page 951-960, June 2026.
Imeglimin exerted neuroprotective effects in a type 1 diabetic neuropathy model, improving sensory nerve conduction, sciatic nerve blood flow, and intraepidermal nerve fiber density. In vitro, imeglimin promoted neurite outgrowth in a DRG‐derived hybridoma cell line, supporting a direct neurotrophic action.
Wataru Nihei   +10 more
wiley   +1 more source

<i>Trans</i>-Chalcone Reduces Inflammation and Pain Triggered by Superoxide Anion: Neuronal and Non-Neuronal Mechanisms. [PDF]

open access: yesJ Inflamm Res
Piva M   +13 more
europepmc   +1 more source

Phenol Neurolysis in Pain and Palliative Medicine

open access: yesPain Practice, Volume 26, Issue 5, June 2026.
ABSTRACT Background Pain is a common symptom in palliative care and affects patients' quality of life considerably. Standard analgesics are sometimes insufficient and are associated with substantial side effects. Neurolysis, the targeted destruction of nerves using thermal or chemical agents, offers an additional option for managing localized pain in ...
Jeroen H. A. Creemers   +6 more
wiley   +1 more source

Protectin DX reduces inflammatory pain initiated by superoxide anion in mice: targeting leukocyte recruitment, oxidative stress, cytokine production and TRPV1<sup>+</sup> nociceptive sensory neuron activation. [PDF]

open access: yesInflamm Res
Carneiro JA   +14 more
europepmc   +1 more source

Evaluating FABP5 as a Therapeutic Target for Pain Management. [PDF]

open access: yesEur J Pain
Warren W   +4 more
europepmc   +1 more source

The nociceptor primary cilium. [PDF]

open access: yesBrain
Ganter GK   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy